Nutrien (NTR) Price Target Raised by UBS Analyst | NTR Stock News

Author's Avatar
May 08, 2025
Article's Main Image

On May 8, 2025, UBS analyst Eric Beaumont maintained a 'Neutral' rating on Nutrien (NTR, Financial) while raising the price target. The previous price target was set at $52.00 USD, which has now been adjusted to $56.00 USD. This adjustment reflects a 7.69% increase in the price target for Nutrien (NTR).

The revised forecast by UBS indicates continued confidence in Nutrien's market performance, whilst maintaining a neutral outlook on the stock. Investors may see this as a steady indication of Nutrien's potential in the current economic climate.

Nutrien (NTR, Financial) continues to be a significant player in the agricultural sector, and the latest analysis by UBS provides updated guidance for traders and investors monitoring the stock's performance.

Wall Street Analysts Forecast

1920556058020048896.png

Based on the one-year price targets offered by 20 analysts, the average target price for Nutrien Ltd (NTR, Financial) is $60.90 with a high estimate of $70.00 and a low estimate of $52.00. The average target implies an upside of 12.02% from the current price of $54.37. More detailed estimate data can be found on the Nutrien Ltd (NTR) Forecast page.

Based on the consensus recommendation from 24 brokerage firms, Nutrien Ltd's (NTR, Financial) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Nutrien Ltd (NTR, Financial) in one year is $49.92, suggesting a downside of 8.18% from the current price of $54.365. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Nutrien Ltd (NTR) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.